Here we employed multiple approaches to provide the first comprehensive analysis of PAK1 in a large series of 176 samples from patients with primary resected GEJ adenocarcinoma and the relevant microarray datasets. This evidence concerns the gene PAK1 and gastroesophageal junction adenocarcinoma.